Resources

1 Resources for

angiodynamics

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Zacks Analyst Blog Highlights: W.R. Berkley and AngioDynamics
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: W.R. Berkley (NYSE: BER) and AngioDynamics (Nasdaq: ANGO). See the...
Tags: AngioDynamics, W.R. Berkley Corp.
Research articles 2007-06-11

Additional Resources

AngioDynamics Comments on Declaratory Judgment Decision by Court
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ:ANGO) today commented on a decision in the U.S. District Court for Delaware concerning a declaratory judgment action brought by AngioDynamics against Diomed, Inc. This case is unrelated to the ongoing litigation brought by Diomed against AngioDynamics and others regarding the '777 patent.
Research articles 2006-09-08
AngioDynamics Inc. to Acquire Rita Medical Systems for 4.74 Times Revenue
The Deal: AngioDynamics Inc. has signed a definitive agreement to acquire Rita Medical Systems Inc. for $220 million in cash and stock. AngioDynamics will also assume about $3.3 million in debt, for a total deal value of $223.3 million. AngioDynamics expects to conclude the transaction in the first calendar quarter...
Tags: RITA Medical Systems Inc.
Research articles 2006-12-04
AngioDynamics: Strong Earnings Despite Diomed Baggage
Douglas Cress submits: The AP has a tendency to turn any earnings misstep into a headline. Such was the case with Thursday’s news that “AngioDynamics 1Q profit slips on lower laser sales”. The Business Review said, “AngioDynamics reports 7.1% drop in 1Q net income.” While true, by most measures, AngioDynamics'...
Tags: Healthcare
External links 2008-10-05
AngioDynamics and RITA Medical Systems Announce Expiration of Hart-Scott-Rodino Waiting Period for RITA Medical Systems Acquisition
QUEENSBURY, N.Y. & FREMONT, Calif. -- AngioDynamics, Inc. (NASDAQ:ANGO) and RITA Medical Systems, Inc. (NASDAQ:RITA) announced today that the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with AngioDynamics' proposed acquisition of RITA had expired. The expiration of the Hart-Scott-Rodino waiting period...
Tags: acquisition, FINANCE, Investment, prospectus, SEC, security, solicitation
Research articles 2007-01-12
AngioDynamics Reports Record Second Quarter.
M2 PRESSWIRE-4 January 2007-Breaking News: AngioDynamics Reports Record Second QuarterC1994-2007 M2 COMMUNICATIONS LTD RDATE:04012007 AngioDynamics, Inc. (NASDAQ:ANGO) is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and ...
Tags: acquisition, Company, FINANCE, Investment, prospectus, SALES, SEC, security, solicitation
Research articles 2007-01-04
AngioDynamics to Present at Needham 9th Annual Growth Stock Conference
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (Nasdaq:ANGO) today announced that Joseph G. Gerardi, AngioDynamics' chief financial officer, will present at Needham & Company's 9th Annual Growth Stock Conference on Thursday, January 11, 2007 at 10:30 a.m. Eastern Time. The conference will be held at the New York Palace Hotel in New...
Tags: acquisition, Company, conference, FINANCE, Investment, prospectus, SEC, security, solicitation, stock
Research articles 2007-01-08
AngioDynamics Inc., F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions. Our first question is from the line of Jason Mills with Canaccord Adams. Jason Mills - Canaccord Adams Eamonn, first I have two questions and then will get back in queue; I wanted to ask you about the leadership transition and specifically your transition...
Tags: Relationship, Call Transcript, Earnings, CEO, AngioDynamics Inc., Leadership, Product Development, Healthcare, Management, Research & Development, Business Operations, Seeking Alpha
Earnings calls 2009-01-06
AngioDynamics Completes RITA Medical Systems Acquisition
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (Nasdaq:ANGO) announced today that it has completed the acquisition of RITA Medical Systems, Inc ("RITA"). As a result of the acquisition, each share of RITA common stock was converted into the right to receive 0.1722 of a share of common stock of AngioDynamics, Inc. and...
Tags: RITA Medical Systems Inc.
Research articles 2007-01-29
E-Z-EM Board Declares Special Dividend of AngioDynamics Shares
LAKE SUCCESS, N.Y. -- E-Z-EM, Inc., (AMEX:EZM) today announced that its Board of Directors has declared a special stock dividend of the 9.2 million shares of common stock of its subsidiary AngioDynamics, Inc., (Nasdaq:ANGO) held by E-Z-EM. The special stock dividend is payable on October 30, 2004 to E-Z-EM shareholders...
Research articles 2004-08-19
AngioDynamics Announces Settlement of Patent Litigation With VNUS Medical Technologies
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it has entered into an agreement that settles all patent litigation with VNUS Medical Technologies. Under...
Tags: patent litigation
Research articles 2008-06-03
AngioDynamics Named to Forbes 200 Best Small Companies List
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced that it was named to the list of the 200 Best Small Companies in America published in the October 30, 2006 issue of Forbes. AngioDynamics was #11 on this prestigious list and was also recognized as one of the best newcomers to...
Tags: Forbes
Research articles 2006-10-18
AngioDynamics to Present at UBS 2006 Global Life Sciences Investor Conference
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ:ANGO) announced that Joseph G. Gerardi, AngioDynamics' chief financial officer, will present at the UBS 2006 Global Life Sciences Conference on Wednesday, September 27, 2006, at 2:00 PM Eastern Time. The conference will be held at the Grand Hyatt Hotel in New York City from...
Tags: UBS AG
Research articles 2006-09-20
AngioDynamics to Present at 19th Annual Piper Jaffray Health Care Conference
QUEENSBURY, N.Y. -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 19th Annual Piper Jaffray Health Care Conference in New York City on...
Tags: Company, conference, HEALTHCARE, surgeon, U.S. Bancorp Piper Jaffray Inc.
Research articles 2007-11-19
AngioDynamics to Acquire RITA Medical for $220 Million
Complementary Products and Shared Customer Bases Provide Clear Strategic Fit Expected to Result in Approximately $0.05 EPS Accretion in Fiscal Year 2008 Conference Call Begins Today at 11:30 a.m. Eastern Time QUEENSBURY, N.Y. & FREMONT, Calif. -- AngioDynamics, Inc. (NASDAQ:ANGO) ("AngioDynamics"), a leading provider of medical devices...
Tags: acquisition, equity, FINANCE, financial, Investment, prospectus, SEC, security, shareholder, surgeon
Research articles 2006-11-28
AngioDynamics Sets Dates for Stockholders' Consideration of RITA Medical Systems Acquisition
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ: ANGO) announced today that a special meeting of stockholders will be held on January 29, 2007, at which stockholders of record at the close of business on December 21, 2006 will be entitled to vote upon a proposal to approve the issuance of common...
Tags: acquisition, AngioDynamics Inc., FINANCE, Investment, prospectus, SEC, security, solicitation
Research articles 2006-12-22
AngioDynamics to make public offering
WESTBURY, N.Y.--HealthWire--Sept. 6, 1996--E-Z-EM Inc., announced today that its AngioDynamics Division will offer up to 20% of its equity to the public.This offering is expected to occur in early 1997 and is expected to be a firm commitment underwriting. This offering will be made only by means of a...
Tags: Westbury Plc.
Research articles 1996-09-06
Zacks.com Announces That Joseph Parnes Highlights the Following Stocks: Angiodynamics, Costco, Walgreen and Marvell Technology
CHICAGO -- The market's stumbling start to 2005 doesn't bode well for the rest of the year, according to Joseph Parnes, editor of the Shortex newsletter. Read about the reasons for January's soft performance, and then learn about Angiodynamics (NASDAQ:ANGO), Costco (NASDAQ:COST), Walgreen (NYSE:WAG) and Marvell Technology (NASDAQ:MRVL). Click here...
Tags: Marvell, Walgreen Co., Costco Wholesale Corp., stock
Research articles 2005-01-17
AngioDynamics receives FDA clearance to market microcatheters for peripheral vascular diagnosis
QUEENSBURY, N.Y.--BUSINESS WIRE--June 10, 1997--AngioDynamics Inc., a wholly owned subsidiary of E-Z-EM Inc. (AMEX: EZM.A and EZM.B) and a manufacturer and global marketer of interventional medical devices for cardiologists and radiologists, today announced that the U.S. Food and Drug Administration FDA has granted 510 k clearance for the company to...
Tags: FDA
Research articles 1997-06-10
AngioDynamics Named One of BusinessWeek's Top 100 Hot Growth Companies for 2005
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced that it was named in the June 6, 2005 issue of BusinessWeek as one of the 100 best small public companies in the United States. The cover page article called "Hot Growth" is a part of an annual survey of top producing...
Tags: BusinessWeek
Research articles 2005-06-02
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement